8YLS
 
 | Structure of SARS-CoV-2 Mpro in complex with its degrader | 分子名称: | (4-methoxyphenyl)methyl ~{N}-[(2~{S})-4-methyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate, 3C-like proteinase nsp5 | 著者 | Feng, Y, Li, W, Cheng, S.H, Li, X.B. | 登録日 | 2024-03-06 | 公開日 | 2024-09-04 | 最終更新日 | 2025-03-19 | 実験手法 | X-RAY DIFFRACTION (1.93 Å) | 主引用文献 | Development of novel antivrial agents that induce the degradation of the main protease of human-infecting coronaviruses. Eur.J.Med.Chem., 275, 2024
|
|
8ZER
 
 | Crystal structure of the complex of Wuhan SARS-CoV-2 RBD (319-541) with P2C5 nanobody | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanobody P2C5, Spike protein S1, ... | 著者 | Sluchanko, N.N, Varfolomeeva, L.A, Shcheblyakov, D.V, Logunov, D.Y, Gintsburg, A.L, Popov, V.O, Boyko, K.M. | 登録日 | 2024-05-06 | 公開日 | 2024-09-04 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (3.1 Å) | 主引用文献 | Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain. Biochemistry Mosc., 89, 2024
|
|
8ZES
 
 | Crystal structure of the Wuhan SARS-CoV-2 RBD (333-541) complexed with P2C5 nanobody | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanobody P2C5, ... | 著者 | Sluchanko, N.N, Varfolomeeva, L.A, Shcheblyakov, D.V, Logunov, D.Y, Gintsburg, A.L, Popov, V.O, Boyko, K.M. | 登録日 | 2024-05-06 | 公開日 | 2024-09-04 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (3.7 Å) | 主引用文献 | Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain. Biochemistry Mosc., 89, 2024
|
|
9EO6
 
 | SARS-CoV2 major protease in complex with a covalent inhibitor SLL11. | 分子名称: | 3C-like proteinase nsp5, Inhibitor SLL11, POTASSIUM ION | 著者 | Moche, M, Lennerstrand, J, Nyman, T, Strandback, E, Akaberi, D. | 登録日 | 2024-03-14 | 公開日 | 2024-09-04 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.11 Å) | 主引用文献 | Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrob.Agents Chemother., 68, 2024
|
|
9EOR
 
 | SARS-CoV2 major protease in complex with a covalent inhibitor SLL12. | 分子名称: | 3C-like proteinase nsp5, Inhibitor SLL12, POTASSIUM ION | 著者 | Moche, M, Lennerstrand, J, Nyman, T, Strandback, E, Akaberi, D. | 登録日 | 2024-03-15 | 公開日 | 2024-09-04 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.25 Å) | 主引用文献 | Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrob.Agents Chemother., 68, 2024
|
|
9EOX
 
 | SARS-CoV2 major protease in covalent complex with a soluble inhibitor. | 分子名称: | 3C-like proteinase nsp5, POTASSIUM ION, Soluble inhibitor | 著者 | Moche, M, Lennerstrand, J, Nyman, T, Strandback, E, Akaberi, D. | 登録日 | 2024-03-15 | 公開日 | 2024-09-04 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.54 Å) | 主引用文献 | Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrob.Agents Chemother., 68, 2024
|
|
8AJ1
 
 | SARS-CoV-2 Mpro in Complex with RK-107 | 分子名称: | (2R,3S)-3-[[(2S)-3-cyclopropyl-2-[2-oxidanylidene-3-(phenylcarbamoylamino)pyridin-1-yl]propanoyl]amino]-N-methyl-2-oxidanyl-4-[(3S)-2-oxidanylidenepyrrolidin-3-yl]butanamide, 3C-like proteinase nsp5 | 著者 | El Kilani, H, Hilgenfeld, R. | 登録日 | 2022-07-27 | 公開日 | 2024-09-11 | 最終更新日 | 2025-01-29 | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | 主引用文献 | Structure-Based Optimization of Pyridone alpha-Ketoamides as Inhibitors of the SARS-CoV-2 Main Protease. J.Med.Chem., 2025
|
|
8Y4A
 
 | BA.2.86 S-trimer in complex with Nab XG2v046 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein, ... | 著者 | Zhu, Q, Liu, P. | 登録日 | 2024-01-30 | 公開日 | 2024-09-11 | 最終更新日 | 2024-10-09 | 実験手法 | ELECTRON MICROSCOPY (3.4 Å) | 主引用文献 | Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope. Signal Transduct Target Ther, 9, 2024
|
|
8U3O
 
 | |
8ZBQ
 
 | |
9ATO
 
 | XBB.1.5 spike/Nanosota-3C complex | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-3C, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2024-02-27 | 公開日 | 2024-09-18 | 最終更新日 | 2025-04-02 | 実験手法 | ELECTRON MICROSCOPY (3.2 Å) | 主引用文献 | Structure-guided in vitro evolution of nanobodies targeting new viral variants. Plos Pathog., 20, 2024
|
|
9ATP
 
 | local refinement of XBB.1.5 spike/Nanosota-3C complex | 分子名称: | Nanosota-3C, Spike glycoprotein | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2024-02-27 | 公開日 | 2024-09-18 | 最終更新日 | 2025-04-02 | 実験手法 | ELECTRON MICROSCOPY (3.5 Å) | 主引用文献 | Structure-guided in vitro evolution of nanobodies targeting new viral variants. Plos Pathog., 20, 2024
|
|
8U9H
 
 | |
8U9K
 
 | |
8U9M
 
 | |
8U9N
 
 | |
8U9T
 
 | |
8U9U
 
 | |
8U9V
 
 | |
8U9W
 
 | |
8WFH
 
 | Crystal structure of Omicron BA.4/5 in complex with a neutralizing antibody scFv D1 | 分子名称: | D1 scFv, Spike protein S1 | 著者 | Terekhov, S.S, Mokrushina, Y.A, Zhang, M, Zhang, N, Gabibov, A, Guo, Y. | 登録日 | 2023-09-19 | 公開日 | 2024-09-25 | 最終更新日 | 2024-11-27 | 実験手法 | X-RAY DIFFRACTION (2.72 Å) | 主引用文献 | Crystal structure of Omicron BA.4/5 in complex with a neutralizing antibody scFv D1 To Be Published
|
|
8WFM
 
 | Crystal structure of Omicron BA.1 in complex with a neutralizing antibody scFv T11 | 分子名称: | Spike protein S1, T11 scFv | 著者 | Terekhov, S.S, Mokrushina, Y.A, Zhang, M, Zhang, N, Gabibov, A, Guo, Y. | 登録日 | 2023-09-19 | 公開日 | 2024-09-25 | 最終更新日 | 2024-11-27 | 実験手法 | X-RAY DIFFRACTION (2.99 Å) | 主引用文献 | Crystal structure of Omicron BA.1 in complex with a neutralizing antibody scFv T11 To Be Published
|
|
9DN4
 
 | Crystal structure of a SARS-CoV-2 20-mer RNA in complex with FAB BL3-6S97N | 分子名称: | CHLORIDE ION, FAB BL3-6S97N HEAVY CHAIN, FAB BL3-6S97N LIGHT CHAIN, ... | 著者 | Lovell, S, Cooper, A, Battaile, K.P, Hegde, S, Wang, J. | 登録日 | 2024-09-16 | 公開日 | 2024-09-25 | 最終更新日 | 2025-07-02 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Mechanistic studies of small molecule ligands selective to RNA single G bulges. Nucleic Acids Res., 53, 2025
|
|
9GNY
 
 | SARS-CoV-2 methyltransferase nsp10-16 in complex with SAM and Caffeine | 分子名称: | 1,2-ETHANEDIOL, 2'-O-methyltransferase nsp16, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, ... | 著者 | Kremling, V, Sprenger, J, Oberthuer, D, Kiene, A. | 登録日 | 2024-09-04 | 公開日 | 2024-09-25 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Crystal structures of SARS-CoV-2 methyltransferase nsp10-16 with Cap0-site binders to be published
|
|
9GRP
 
 | SARS-CoV-2 methyltransferase nsp10-16 in complex with SAM and beta-chloroethyl theophylline | 分子名称: | 1,2-ETHANEDIOL, 2'-O-methyltransferase nsp16, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, ... | 著者 | Kremling, V, Sprenger, J, Oberthuer, D, Kiene, A. | 登録日 | 2024-09-12 | 公開日 | 2024-09-25 | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | 主引用文献 | Crystal structures of SARS-CoV-2 methyltransferase nsp10-16 with Cap0-site binders To Be Published
|
|